Ampicillin for Injection — Class II drug recall D-1542-2022
Terminated recall by Viatris Inc, reported 2022-10-05, distributed nationwide. Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vi
| Recall number | D-1542-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Viatris Inc, Canonsburg, PA, United States |
| Recall initiated | 2022-09-21 |
| Classified | 2022-09-23 |
| Reported by FDA | 2022-10-05 |
| Terminated | 2023-10-31 |
| Distributed | Nationwide (US) |
| Quantity | 3,931 cartons |
| Reason classes | specification failure |
| NDC | 67457-0352-02, 67457-0352-10 |
| Lot numbers | 7105130 |
| Expiration dates | 2023-09 |
Product
Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A
Reason for recall
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1542-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.